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SESSION INFORMATION
Background/Purpose:
The innate immune system is important for initiation and development of OA. Increased
degradation of the cartilage release fragments into the synovial fluid, which can then bind to
innate immune receptors in the synovium. The aim of this study was to investigate the effect of
Toll like receptor 2 (TLR2) activation by synthetic agonists and a synthetic aggrecan 32 amino acid
fragment (32-mer) on the tissue turnover and IL-6 secretion, in a human synovial membrane
explant model.
  Methods:
Human synovial membrane biopsies retrieved from OA patients undergoing total knee
replacement were lysed and the presence of TLR2 were investigated by western blotting. Human
synovial membrane explants (SME) were prepared from the synovial biopsies: Excess fat was
removed and the biopsies were cut into explants of 30±5 mg. The SMEs were cultured for 14 days
without treatment (WO), OSM [10ng/mL] + TNFα [20ng/mL] (positive control), Pam2CSK4 in three
doses (100 ng/mL, 10 ng/mL, or 1 ng/mL), or Pam3CSK4 in three doses (300 ng/mL, 30  ng/mL, or 3
ng/mL). Furthermore, stimulation with a synthetic aggrecan 32-mer (100000 ng/mL, 10000 ng/ml,
1000 ng/ml, 100 ng/ml and 10 ng/ml, respectively) was evaluated. Release of the neo-epitope
biomarkers acMMP3 and C3M were measured by ELISA and secretion of IL-6 was evaluated by
western blotting at day 5 and 10 in the conditioned media.  
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  Results:
Western blotting confirmed the presence of TLR2 in untreated OA synovial biopsies (Fig. 1a).
Activation of the SMEs were assessed by acMMP3, C3M, and IL-6 release. OSM+TNFα significantly
increased the release of IL-6 secretion, acMMP3 (P<0.05), and C3M (P<0.01) (Fig. 1). The TLR2
agonists, Pam2CSK4 and Pam3CSK3, significantly increased the release of acMMP3 at day 10
compared to WO (PAM2CSK4: 100 ng/mL P <0.001, 10 ng/mL P=0.016, Pam3CSK4: 30 ng/mL
P<0.001) (Fig. 1c). The overall C3M release was significantly increased by Pam2CSK compared to
WO (100 ng/mL P=0.007 and 10 ng/mL: P=0.008) (Fig. 1d). Pam3CSK tended to increase the overall
C3M and significantly increased C3M release at day 10 compared to WO (100 ng/mL: P=0.035, 10
ng/mL: P=0.008). The western blotting confirmed increased secretion of IL-6 from SMEs stimulated
with Pam2CSK4 (Fig. 1b) and Pam3CSK4 compared to WO. Synthetic aggrecan 32-mer did not
show any significant increase of C3M release from the synovium.  
  Conclusion:
TLR2 is expressed in synovium of OA patients and their activation by synthetic ligands resulted in
increased tissue turnover confirmed by release of activated MMP3, acMMP3, and MMP-mediated
degradation of type III collagen, C3M. Additionally, activation of TLR2 lead to an increased
secretion of the pro-inflammatory cytokine IL-6. A synthetic peptide of the potential biological
ligand of TLR2, the aggrecan 32-mer failed to generate a significant C3M response compared to
WO. We hypothesize that it may be different with the glycosylated native aggrecan 32-mer.
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